To assess the alleged involvement of SCD1 in the fibroblast-triggered improvement of cancer cell migration (Angelucci et al, 2012), both siRNA knockdown and pharmacologic inhibition of SCD1 was performed in cancer cells with a resulted impairment of their migratory ability. Here, SCD is linked to cancer.